WHO ICTRP trial

Effects of Esketamine Combined with Sufentanil for Postoperative Analgesia on…

ChiCTR2500102614 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500102614
Public title Effects of Esketamine Combined with Sufentanil for Postoperative Analgesia on Postoperative Anxiety and Depression in Breast Cancer Patients with Preoperative Anxiety:a single-center, double blind, prospective, randomized controlled, clinical study
Scientific title Effects of Esketamine Combined with Sufentanil for Postoperative Analgesia on Postoperative Anxiety and Depression in Breast Cancer Patients with Preoperative Anxiety
Primary sponsor Tangdu Hospital, Air Force Military Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Countries China
Conditions Anxiety and Depression
Interventions Test group H:1.0ug/kg Sufentanil +0.5mg/kg esketamine +5mg tropisetron +2ug/kg dexmetopidine was prepared into 100ml with sodium chloride and added to the postoperative analgesic pump;Test group L:1.0ug/kg Sufentanil +0.3mg/kg esketamine…
Registration date May 16, 2025
Target size Test group H:22;Test group L:22;Control group:22
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations